The Federal Government has reinforced its backing of the nirmatrelvir plus ritonavir oral antiviral (sold as Paxlovid) by placing another half a million treatment courses on order ahead of its listing on the Pharmaceutical Benefits Scheme (PBS).
from Google Alert - health https://ift.tt/n7U4trk
via IFTTT
0 comments:
Post a Comment